Shailja Shah
Last active: 3/3/2020


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Surveillance of Gastric Intestinal Metaplasia. Shah SC, Gawron AJ, Li D (2020) Am J Gastroenterol 115(5): 641-644
    › Primary publication · 32058339 (PubMed) · PMC7364865 (PubMed Central)
  2. Spotlight: Gastric Intestinal Metaplasia. Shah SC, Gupta S, Li D, Morgan D, Mustafa RA, Gawron AJ (2020) Gastroenterology 158(3): 704
    › Primary publication · 32035529 (PubMed)
  3. Occupational exposures and odds of gastric cancer: a StoP project consortium pooled analysis. Shah SC, Boffetta P, Johnson KC, Hu J, Palli D, Ferraroni M, Tsugane S, Hamada GS, Hidaka A, Zaridze D, Maximovich D, Vioque J, Navarrete-Munoz EM, Zhang ZF, Mu L, Boccia S, Pastorino R, Kurtz RC, Rota M, Bonzi R, Negri E, La Vecchia C, Pelucchi C, Hashim D (2020) Int J Epidemiol 49(2): 422-434
    › Primary publication · 31965145 (PubMed)
  4. Ulcerative Colitis: Current and Emerging Treatment Strategies. Kayal M, Shah S (2019) J Clin Med 9(1)
    › Primary publication · 31905945 (PubMed) · PMC7019865 (PubMed Central)
  5. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB (2020) Gastroenterology 158(3): 745-750
    › Primary publication · 31887261 (PubMed) · PMC7302270 (PubMed Central)
  6. Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan DR (2020) Gastroenterology 158(3): 751-759
    › Primary publication · 31887260 (PubMed) · PMC7354093 (PubMed Central)
  7. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA (2020) Gastroenterology 158(3): 732-744.e16
    › Primary publication · 31816301 (PubMed) · PMC7425600 (PubMed Central)
  8. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA (2020) Gastroenterology 158(3): 705-731.e5
    › Primary publication · 31816300 (PubMed) · PMC7375032 (PubMed Central)
  9. Associations between calcium and magnesium intake and the risk of incident gastric cancer: A prospective cohort analysis of the National Institutes of Health-American Association of Retired Persons (NIH-AARP) Diet and Health Study. Shah SC, Dai Q, Zhu X, Peek RM, Smalley W, Roumie C, Shrubsole MJ (2020) Int J Cancer 146(11): 2999-3010
    › Primary publication · 31472027 (PubMed) · PMC7048631 (PubMed Central)
  10. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance. Mahmoud R, Shah SC, Torres J, Castaneda D, Glass J, Elman J, Kumar A, Axelrad J, Harpaz N, Ullman T, Colombel JF, Oldenburg B, Itzkowitz SH (2020) Clin Gastroenterol Hepatol 18(7): 1518-1527.e3
    › Primary publication · 31446183 (PubMed) · PMC7354098 (PubMed Central)
  11. Friend or Foe in Inflammatory Bowel Disease Pathogenesis: Not All Infections Are Equal. Shah SC (2019) Gastroenterology 157(5): 1441-1442
    › Primary publication · 31442437 (PubMed)
  12. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies. Agrawal M, Shah S, Patel A, Pinotti R, Colombel JF, Burisch J (2019) J Autoimmun : 102303
    › Primary publication · 31351784 (PubMed) · PMC7382899 (PubMed Central)
  13. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S, New York Crohn’s and Colitis Organization (2020) Clin Gastroenterol Hepatol 18(4): 872-880.e1
    › Primary publication · 31302306 (PubMed) · PMC7354097 (PubMed Central)
  14. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Tepler A, Narula N, Peek RM, Patel A, Edelson C, Colombel JF, Shah SC (2019) Aliment Pharmacol Ther 50(2): 121-131
    › Primary publication · 31165513 (PubMed) · PMC7393806 (PubMed Central)
  15. Upper Endoscopy up to 3 Years Prior to a Diagnosis of Gastric Cancer Is Associated With Lower Stage of Disease in a USA Multiethnic Urban Population, a Retrospective Study. Shah SC, Nakata C, Polydorides AD, Peek RM, Itzkowitz SH (2019) J Prev Med Public Health 52(3): 179-187
    › Primary publication · 31163953 (PubMed) · PMC6549011 (PubMed Central)
  16. Increased Incidence and Mortality of Gastric Cancer in Immigrant Populations from High to Low Regions of Incidence: A Systematic Review and Meta-Analysis. Pabla BS, Shah SC, Corral JE, Morgan DR (2020) Clin Gastroenterol Hepatol 18(2): 347-359.e5
    › Primary publication · 31154030 (PubMed) · PMC6911018 (PubMed Central)
  17. Management of Inflammatory Bowel Disease-Associated Dysplasia in the Modern Era. Shah SC, Itzkowitz SH (2019) Gastrointest Endosc Clin N Am 29(3): 531-548
    › Primary publication · 31078251 (PubMed) · PMC7354094 (PubMed Central)
  18. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Limketkai BN, Shah SC, Hirano I, Bellaguarda E, Colombel JF (2019) Gut 68(12): 2152-2160
    › Primary publication · 30923072 (PubMed)
  19. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? Shah SC, Kayamba V, Peek RM, Heimburger D (2019) J Glob Oncol : 1-8
    › Primary publication · 30908147 (PubMed) · PMC6452918 (PubMed Central)
  20. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF (2019) Aliment Pharmacol Ther 49(7): 904-911
    › Primary publication · 30773656 (PubMed)
  21. Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen . Suarez G, Romero-Gallo J, Piazuelo MB, Sierra JC, Delgado AG, Washington MK, Shah SC, Wilson KT, Peek RM (2019) Cancer Res 79(7): 1600-1611
    › Primary publication · 30696658 (PubMed) · PMC6445772 (PubMed Central)
  22. Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysis. Shah SC, Tepler A, Peek RM, Colombel JF, Hirano I, Narula N (2019) Clin Gastroenterol Hepatol 17(11): 2185-2198.e3
    › Primary publication · 30659992 (PubMed) · PMC7354099 (PubMed Central)
  23. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis. Choy MC, Seah D, Faleck DM, Shah SC, Chao CY, An YK, Radford-Smith G, Bessissow T, Dubinsky MC, Ford AC, Churilov L, Yeomans ND, De Cruz PP (2019) Inflamm Bowel Dis 25(7): 1169-1186
    › Primary publication · 30605549 (PubMed) · PMC6783899 (PubMed Central)
  24. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases. Mahmoud R, Shah SC, Ten Hove JR, Torres J, Mooiweer E, Castaneda D, Glass J, Elman J, Kumar A, Axelrad J, Ullman T, Colombel JF, Oldenburg B, Itzkowitz SH, Dutch Initiative on Crohn and Colitis (2019) Gastroenterology 156(5): 1333-1344.e3
    › Primary publication · 30529584 (PubMed) · PMC7354096 (PubMed Central)
  25. Carcinogenic Strains Selectively Dysregulate the Gastric Proteome, Which May Be Associated with Stomach Cancer Progression. Noto JM, Rose KL, Hachey AJ, Delgado AG, Romero-Gallo J, Wroblewski LE, Schneider BG, Shah SC, Cover TL, Wilson KT, Israel DA, Roa JC, Schey KL, Zavros Y, Piazuelo MB, Peek RM (2019) Mol Cell Proteomics 18(2): 352-371
    › Primary publication · 30455363 (PubMed) · PMC6356085 (PubMed Central)
  26. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Shah SC, Glass J, Giustino G, Hove JRT, Castaneda D, Torres J, Kumar A, Elman J, Ullman TA, Itzkowitz SH (2019) Gut Liver 13(1): 54-61
    › Primary publication · 30400722 (PubMed) · PMC6346999 (PubMed Central)
  27. Microbial-Host Interactions in Inflammatory Bowel Disease, Functional Bowel Disease, Obesity and Obesity-Related Metabolic Disease. Shah SC, Faith J, Colombel JF (2018) Gastroenterology 155(5): 1283-1286
    › Primary publication · 30176219 (PubMed)
  28. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel JF (2018) Gastroenterology 155(4): 1079-1089.e3
    › Primary publication · 29958857 (PubMed)
  29. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC (2018) Gastroenterology 155(3): 648-660
    › Primary publication · 29778607 (PubMed)
  30. Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study. Ten Hove JR, Shah SC, Shaffer SR, Bernstein CN, Castaneda D, Palmela C, Mooiweer E, Elman J, Kumar A, Glass J, Axelrad J, Ullman TA, Colombel JF, Torres J, van Bodegraven AA, Hoentjen F, Jansen JM, de Jong ME, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Itzkowitz SH, Oldenburg B (2019) Gut 68(4): 615-622
    › Primary publication · 29720408 (PubMed)
  31. Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders. Hirten RP, Iacucci M, Shah S, Ghosh S, Colombel JF (2018) Clin Gastroenterol Hepatol 16(9): 1374-1384
    › Primary publication · 29481970 (PubMed)
  32. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J (2018) Clin Gastroenterol Hepatol 16(7): 1106-1113.e3
    › Primary publication · 29378311 (PubMed)
  33. Current Management of Benign Epithelial Gastric Polyps. Cheesman AR, Greenwald DA, Shah SC (2017) Curr Treat Options Gastroenterol 15(4): 676-690
    › Primary publication · 28975540 (PubMed)